Metraipolis › archive › dc_2ceb3b85dfd1

Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease — Europe PMC PMID:41971092

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41971092
DOI: 10.3389/fphar.2026.1775516
License (as archived): solo-consultazione
Archived: 2026-11-03T20:07:34.854Z
SHA-256 of the archived text: 3c2f2fd23c1589271a98ed0359f17a8e8c7ee9d590944eecf35f464fbafef73e
Stable URL of this page: https://metraipolis.com/documento/dc_2ceb3b85dfd1

How to cite

Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease — Europe PMC PMID:41971092 — Europe PMC (en), https://europepmc.org/article/MED/41971092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ceb3b85dfd1 (Metraipolis archive dc_2ceb3b85dfd1, sha256 3c2f2fd23c1589271a98ed0359f17a8e8c7ee9d590944eecf35f464fbafef73e)

BibTeX

@misc{dc2ceb3b85dfd1,
  title = {Clinical efficacy of PPAR agonists in the treatment of nonalcoholic fatty liver disease — Europe PMC PMID:41971092},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41971092},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ceb3b85dfd1; sha256 3c2f2fd23c1589271a98ed0359f17a8e8c7ee9d590944eecf35f464fbafef73e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41971092. Agents can read the archived copy with the MCP tool read_document.